Home
About
Overview
Sharing Data
ORCID
Help
History (44)
Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.
Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective.
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
Reply: The LVAD in the Management of Advanced Heart?Failure Due to Hypertrophic Cardiomyopathy.
Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease.
See All 44 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease.
Gange CA, Link MS, Maron MS. Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease. Circulation. 2009 Sep 29; 120(13):e96-7.
View in:
PubMed
subject areas
Electrocardiography
Fabry Disease
Humans
Hypertrophy, Left Ventricular
Magnetic Resonance Imaging
Male
Middle Aged
Myocardium
authors with profiles
Martin S Maron MD, MSPH